Sera Prognostics (SERA) Cash from Operations (2020 - 2026)
Sera Prognostics (SERA) posted Cash from Operations of 8774000.0 for Q1 2026, down 43.37% on a QoQ basis from 6120000.0 in Q4 2025, and down 16.17% year-over-year from 10465891.03 in Q1 2025.
Sera Prognostics (SERA) Cash from Operations (2020 - 2026) Analysis & Trends
Sera Prognostics' Cash from Operations history runs 7 years deep, the most recent figure standing at 8774000.0 for Q1 2026.
- Quarterly Cash from Operations fell 16.17% year-over-year to 8774000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26844000.0 (changed 0.4% YoY) and the FY2025 annual result came in at 25623000.0, down 80.58% from the prior year.
- Cash from Operations was 8774000.0 for Q1 2026 at Sera Prognostics, down from 6120000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4994000.0 in Q1 2024 and bottomed at 9557000.0 in Q1 2022.
- A 5-year average of 6493176.47 and a median of 6995000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations jumped 202.32% — and 2025, when it plunged 251.24%.
- Sera Prognostics' Cash from Operations stood at 7238000.0 in 2022, then gained by 6.53% to 6765000.0 in 2023, then grew by 7.46% to 6260000.0 in 2024, then increased by 2.24% to 6120000.0 in 2025, then tumbled by 43.37% to 8774000.0 in 2026.
- Business Quant data shows SERA's Cash from Operations at 8774000.0 in Q1 2026, 6120000.0 in Q4 2025, and 6477000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 525.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 290.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 220.10 Mn |
| 10 | Sera Prognostics | 105.54 Mn | 105.54 Mn | -28,000.00 | -8.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.77 Mn |
| Mar 31, 2026 | -8.77 Mn |
| Dec 31, 2025 | -6.12 Mn |
| Dec 31, 2025 | -6.12 Mn |
| Sep 30, 2025 | -6.48 Mn |
| Sep 30, 2025 | -6.48 Mn |
| Jun 30, 2025 | -5.47 Mn |
| Jun 30, 2025 | -5.47 Mn |
| Mar 31, 2025 | -7.55 Mn |
| Mar 31, 2025 | -7.55 Mn |
| Dec 31, 2024 | -6.26 Mn |
| Dec 31, 2024 | -6.26 Mn |
| Sep 30, 2024 | -7.00 Mn |
| Sep 30, 2024 | -7.00 Mn |
| Jun 30, 2024 | -5.93 Mn |
| Jun 30, 2024 | -5.93 Mn |
| Mar 31, 2024 | 4.99 Mn |
| Mar 31, 2024 | 4.99 Mn |
| Dec 31, 2023 | -6.77 Mn |
| Dec 31, 2023 | -6.77 Mn |